"On potential partners. The company will keep them informed of sales as well as insurance updates."
The company needs to keep shareholders informed FIRST!!!! We are the fkin owners of the company. Not the fkin potential partners. Which business school did you guys attend? DAMNITTT!! You fools are r3tard2d!!!!
That is B--Shh!! The volume would tell you if it was following the market. 50% average volume suggests no one cared for what they had to say today. There was also zero pre-market trade despite the fact that the numbers were released at 7am.
Idiotic excuses made for this company is just astounding.
It didn't take you long to realize that the only way to relate to these clowns is to call them names. You gotta laugh it off, I swear! lol
Biotia then suggests that you are scaring off investors and short. If you don't agree with him, then you're short. This is fkin $1.15 stock for crying out loud!!! Who the hell would waste time shorting that??
Herd and penny shifting mentality on this board is fricken frightening! No wonder the PPS stinks!
Cut the fkin BS!! Which part of this morning's call had "incredible numbers"?
I'm starting to think many of clowns actually work for the company directly.
We have so many numbers for centers and doctors. Can we get the numbers that actually count? i.e. How many patients are on the waiting list for the certified doctors?
" It was odd that they had it posted on their website for April 29th, and then they pulled it, ... only to announce their results on the 30th, an update on "progress", and then instead not have a CC mentioned."
How many times have they pulled inexperienced shh like this on us? This is a terrible management team with no tactical awareness. You can forget strategic awareness. So many missteps, missed conferences, never forthcoming and the list goes on.
They keep talking about opened centers. I mean seriously, who gives a shhh about open centers. Target opened 133 stores in Canada but was that the full story? We all know how that ended.
What they need to be doing is quantifying demand. What is defines demand? 10, 1,000, 10,000?
Then you have a cash position and the insane burn rate. Heck, admin expenses alone was $4.3million.
There are way too many questions for these guys but of course no one would ever hold them accountable so they would keep walking home with their nice salary.
Obviously - YOURS!!! You're smart enough to figure that was a mistake.
Be truthful in your assessment and get out of the mentality that anyone that calls it what it is is short. Keep it real as a true shareholder should, Pharm!!
No no! Not for you and I. But for the management team and their underwriters that they share bed with.
"We believe that our current resources will permit us to continue to execute on our commercial strategy as we develop the options we have to strengthen our balance sheet in support of our growth strategy into 2016."
First, commercial strategy should have been in place right after AdCom. It is idiotic of the team to now be suggesting that the whole of 2015 is more or less going to be about planning. We should be selling the fkin product by now.
For those of you sitting there micro-researching this company, I cannot even begin to illustrate how misguided many of you are. You pretend to be well versed in your analysis of what constitutes a great opportunity and you have decided that ETRM is the absolute apex-opportunity.
Well sadly, you're all too naive to even save yourselves of daily torture.
OH YES, I am LONG! But I damn well understand and have long accepted the fact that I made the wrong decision investing in ETRM at the time that I did (May 2014). This will continue to be a cash cow for the management until further notice. I can hear you whisper: "Why is he not selling?" I am not selling because I'm holding onto that faint "hope". That market can indeed pick a day and a stock to send parabolic for no real reason based on fundamentals. Besides, I've already written off my bad hand in this.
For the newcomers; do not follow the messages you read on this board urging you to buy as soon as possible. This company is dire straits and burning through cash with ATM to get them out of jail. Sadly, ATM means bad news for shareholders.
In close, don't get your hopes up thinking you would make sizable income from this stock anytime soon. Manage your risks accordingly and read the writings on the wall. Do not let overzealous posters drag you into this without first understanding and embracing the risks that come with it.
It gets tiring, Montana. lol.. When you hear the same shhh for a whole year holding a position that is deep in the red and living through all what should have been great catalysts, the same ol' "future is bright" shhh based on macro information gets tiring.
I've been following BIND for a while but the PPS ran away from me. But this morning I was able to pick a good block. It could still technically go lower to $5 when I look at the chart. But in this game, you can never really pick the exact bottom. So I'm fine with around 20% further downside risk but I'm look for greater upside.
Perhaps you guys are idiots for trying to figure this out at the macro level with each second of the day. GESSS!!! Get a job, fools and stop stalking the stock!
This is small-cap biotech investment 101, Mark. It has nothing to do with "hope" and future. For every investment made, especially in small cap biotech, there is always a risk. The problem here is that not a single soul on this board ever considers the risk but are all too happy to claim that the stock is undervalued. What exactly supports that claim of "undervalued" stock when there is no revenue?
Yes, there is "hope" for the future. But that hope is perfectly hedged against execution, positive cashflow and high demand for vBloc. Visit any biotech board and you're met with overzealous estimates - heck foolish Ade even posted $300 and still got entertained. GALE, RGDX, DSCO, KERX etc are all plagued with zealots. Even when CLDX rallied from $2.05 close to $40, yet many held on expecting that it would reach $120 by end of 2014 based on their calculations. It eventually retreated to $10 before bouncing again in Q1 this year.
The point is, I've been in this game long enough to know most posters blow smoke and often neglect the risks involved in dealing with a company that is still trying to find its feet. Number of centers opened is not indicative of how many surgeries they would perform or how that translates into profitable business and dramatic PPS appreciation for shareholders.
So yes, I still have my shares @ $1.44. But I am very pragmatic in sitting here thinking that somehow this would magically turn into $10 without proof from management that - 1. there is plan for positive cashflow, and 2. There is quantifiable demand for the product. We are in the dark on both points. Therefore, caution is required until further notice.
For all that it is worth, I do hope many here are smart enough to not put more than 20% of their cash into any small cap biotech. Especially ETRM!!
It is astounding how many numbers are thrown around on this board yet not a single message to discuss cashflow issue. As a matter of fact, you would be perceived as a short if you ever bring that up.
Meh! Wackos throwing numbers around are rarely right in this game. Those who sit tight without crazy expectations end up as the real winners.
Day in, day out, everyone on this insane board throws in ridiculous projections without ever considering the risks involved in a market place. Crazy board full of wackos!
No they do not HARM value. They indirectly give value back to shareholders. Yes, buybacks do not offer instant gratification but in the long run, the value will be realized. SWHC and AAPL on my recent list embanked on buybacks but it actually took months to materialize in their respective PPS.